Abstract
With advances in stem cell biology, tissue engineering is becoming increasingly powerful for tissue regeneration. Stem cells with capacity of multilineage and self-renewal are an ideal cell source for tissue engineering. This review focus on discussing the potential strategies including stem cell sources, bio-scaffolds, mechanical stimulation, genetic modification and co-culture techniques to direct ocular-lineage differentiation of stem cells for complete or partial eye regeneration and research. Attempts to use embryonic and somatic stem cells as seed cells for ocular tissue engineering have achieved encouraging results. The combination of chemical and physical signals in stem cell microenvironment could be regulated to induce differentiation of the embryonic stem cells into ocular tissue. This paper present here a broad introduction to the stem cell mediated correction of eye ailments and provide extensive references for the interested reader. This paper also looks into the different aspects of using stem cells for drug development for treating eye ailments.
Keywords: optic nerve, drug development, stem cell microenvironment, ocular-lineage differentiation, co-culture techniques, bio-scaffolds, multilineage and self-renewal, tissue regeneration, tissue engineering, stem cell, retina, ocular diseases, eye, Cornea
Current Topics in Medicinal Chemistry
Title: Stem Cells for Ocular Tissue Engineering and Regeneration
Volume: 11 Issue: 13
Author(s): Radhakrishna Gopala Pillai
Affiliation:
Keywords: optic nerve, drug development, stem cell microenvironment, ocular-lineage differentiation, co-culture techniques, bio-scaffolds, multilineage and self-renewal, tissue regeneration, tissue engineering, stem cell, retina, ocular diseases, eye, Cornea
Abstract: With advances in stem cell biology, tissue engineering is becoming increasingly powerful for tissue regeneration. Stem cells with capacity of multilineage and self-renewal are an ideal cell source for tissue engineering. This review focus on discussing the potential strategies including stem cell sources, bio-scaffolds, mechanical stimulation, genetic modification and co-culture techniques to direct ocular-lineage differentiation of stem cells for complete or partial eye regeneration and research. Attempts to use embryonic and somatic stem cells as seed cells for ocular tissue engineering have achieved encouraging results. The combination of chemical and physical signals in stem cell microenvironment could be regulated to induce differentiation of the embryonic stem cells into ocular tissue. This paper present here a broad introduction to the stem cell mediated correction of eye ailments and provide extensive references for the interested reader. This paper also looks into the different aspects of using stem cells for drug development for treating eye ailments.
Export Options
About this article
Cite this article as:
Gopala Pillai Radhakrishna, Stem Cells for Ocular Tissue Engineering and Regeneration, Current Topics in Medicinal Chemistry 2011; 11 (13) . https://dx.doi.org/10.2174/156802611796117559
DOI https://dx.doi.org/10.2174/156802611796117559 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuroprotective Effects of Low-dose Lithium in Individuals at Ultra-high Risk for Psychosis. A Longitudinal MRI/MRS Study
Current Pharmaceutical Design Defining the Mechanism of Action of 4-Phenylbutyrate to Develop a Small-Molecule-Based Therapy for Alzheimers Disease
Current Medicinal Chemistry The Central Role of Angiotensin I-Converting Enzyme in Vertebrate Pathophysiology
Current Topics in Medicinal Chemistry A Friend in Need May Not be a Friend Indeed: Role of Microglia in Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Possible Neuroprotective Strategies in ALS
Current Neuropharmacology Age-Related Changes in Motor Cortical Properties and Voluntary Activation of Skeletal Muscle
Current Aging Science Polyphenols Beyond Barriers: A Glimpse into the Brain
Current Neuropharmacology Anti-Oxidants in Parkinson’s Disease Therapy: A Critical Point of View
Current Neuropharmacology The Genetics of Frontotemporal Dementia and Related Disorders
Current Genomics Neurorescue Activity, APP Regulation and Amyloid-β Peptide Reduction by Novel Multi-Functional Brain Permeable Iron- Chelating- Antioxidants,M-30 and Green Tea Polyphenol, EGCG
Current Alzheimer Research Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer’s Disease
Current Neuropharmacology Partnerships Between Philanthropy, Government and Investors are Needed to Advance Drug Discovery for Neurodegenerative Diseases
Current Alzheimer Research Preclinical Studies and Clinical Trials with Mesenchymal Stem Cell for Demyelinating Diseases: A Systematic Review
Current Stem Cell Research & Therapy The Chaperone-like Activity of Rat HspB8/Hsp22 and Dynamic Molecular Transition Related to Oligomeric Architectures In Vitro
Protein & Peptide Letters Editorial (Hot Topic: Targeting Histone Acetylation for Neuroprotection)
Current Pharmaceutical Design Discovering New Treatments for Alzheimer's Disease by Repurposing Approved Medications
Current Topics in Medicinal Chemistry Aluminum Vaccine Adjuvants: Are they Safe?
Current Medicinal Chemistry Identification and Characterization of Follistatin-Related Protein-1 Involved in the Regulation of Chinese Perch Skeletal Muscle Hyperplasia
Current Molecular Medicine RNA Interference and Amyotrophic Lateral Sclerosis
Current Drug Metabolism Exploring the Anti-Neuroinflammatory Potential of Steroid and Terpenoid-Derived Phytochemicals to Combat Alzheimer's Disease
Current Pharmaceutical Design